Daré Bioscience Shares Corporate Presentation (Sept 9, 2026)

What Happened Daré Bioscience, Inc. (DARE) filed a Form 8-K on September 9, 2026 (Item 7.01) to furnish a corporate presentation dated September 9, 2026 as Exhibit 99.1. The company said it will use this presentation in meetings with securities market participants beginning September 9, 2026 and will post a copy to the “Presentations, Events & Webcasts” page in the Investors section of its website.

Key Details

• Filed Form 8-K on September 9, 2026 under Item 7.01 (Regulation FD Disclosure).
• Corporate presentation dated September 9, 2026 furnished as Exhibit 99.1.
• Company intends to use the presentation in investor and securities market participant meetings starting Sept 9, 2026.
• The presentation will be made available on Daré’s investor website; information on the website is not incorporated by reference into the 8-K.

Why It Matters This is a Regulation FD disclosure providing investors with updated corporate materials that Daré will use in external meetings. It does not report earnings, management changes, mergers, or financial results—only the furnishing of a presentation. Investors who want the company’s latest investor-facing slides can view the presentation on Daré’s investor website.